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Abstract
Cancer development results from deregulated control of stem cell populations and alterations in their
surrounding environment. Notch signaling is an important form of direct cell-cell communication
involved in cell fate determination, stem cell potential and lineage commitment. The biological
function of this pathway is critically context-dependent. Here we review the pro-differentiation role
and tumor suppressing function of this pathway, as revealed by loss of function in keratinocytes and
skin, downstream of p53 and in cross-connection with other determinants of stem cell potential and/
or tumor formation, like p63 and Rho/CDC42 effectors. The possibility that Notch signaling elicits
a duality of signals, involved in growth/differentiation control and cell survival will be discussed, in
the context of novel approaches for cancer therapy.
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Introduction
Cancer development is the combined result of deregulated stem cell populations and alterations
in their surrounding environment. Cell and tissue homeostasis is achieved by a complex
interplay of signaling pathways, coordinating behavior of a cell with its neighbors in a closely
integrated fashion. Thus, the biological function of individual cell regulatory pathways can
only be understood within the specific cells and tissues in which they operate. This is
particularly relevant for Notch signaling, and its highly context-dependent function in different
cell types and, within the same cell type, at different developmental stages and under normal
versus pathological conditions. At the basis of the context-dependent function of Notch, three
determinants of specificity can be envisaged: a) cross-talk of Notch signaling with cell-type
specific regulatory molecules; b) cell-type specific cross-talk of Notch with other regulatory
pathways, which are themselves not cell type specific; c) cell type- and tissue-specific global
organization, to which Notch contributes and in the context of which it functions.
In mammalian systems, Notch activation is generally held to promote cancer development,
while it can also play an opposite role. Biologically, this is not surprising, in view of the opposite
role that Notch can play in enhancing stem cell potential and suppressing differentiation along
certain lineages, while promoting commitment to others (Artavanis-Tsakonas et al., 1999).
The focus of this review is on the function of Notch in the skin/keratinocyte system, where
loss of function experiments have unequivocally demonstrated a tumor suppressing function
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of this pathway in both mice and humans (Nicolas et al., 2003; Proweller et al., 2006; Lefort
et al., 2007). Similar suppressing function is also possible for other tumor types, as suggested
by the decreased expression and/or activity of endogenous Notch receptors in these tumors and
the growth inhibitory effects exerted by increased Notch activity in the corresponding cells
(Sriuranpong et al., 2001; Sriuranpong et al., 2002; Kunnimalaiyaan et al., 2006; Chen et al.,
2007; Zheng et al., 2007). Importantly, however, besides control of stem cell renewal and
differentiation, Notch signaling plays a pivotal role in cell survival, in a manner that can deeply
influence the final outcome in tumor development. As discussed at the end, this limits the
dichotomy between tumor-promoting and suppressing function, and has important
implications for Notch signaling as a multifaceted target for novel approaches of cancer
therapy.
Notch as a negative regulator of keratinocyte stem cell potential and inducer
of differentiation
Notch signaling involves a direct form of cell-cell communication, whereby non-diffusible
ligands expressed at the surface of a cell engage and activate cognate receptors on its neighbor
(Bray, 2006). The best characterized “canonical” pathway of Notch activation involves
proteolytic cleavage and translocation of the cytoplasmic domain of the receptor to the nucleus,
where it associates with the DNA binding protein CSL converting it from a repressor into an
activator of transcription (Mumm and Kopan, 2000; Lai, 2002). However, direct binding of
Notch to a second ancillary protein, Mastermind-like 1–3 (MamL 1–3), is required for elevated
levels of CSL-dependent transcriptional activation through recruitment of further
transcriptional co-activators such as p300 (Petcherski and Kimble, 2000; Wu et al., 2000;
Oswald et al., 2001). The best characterized targets of Notch/CBF-1/MamL mediated
activation are members of the HES and HERP families of bHLH transcriptional repressors
(Iso et al., 2003). However, a number of other direct targets of Notch/CBF-1 transcription have
been identified, which can be induced by Notch activation in a cell type specific manner.
Direct cell-cell communication by Notch is employed for “lateral inhibition”, a process
whereby negative cross-regulation between Notch and its ligand(s) in equipotent progenitors
produces cells with divergent cell fates (Bray, 2006). Notch and its ligands can also be part of
a positive feedback mechanism; here, Notch-dependent up-regulation of ligand expression and
consequent reinforcement of Notch activation are involved in the coordination of
differentiation along the same lineage. Both mechanisms are likely to operate in mammalian
skin. In human epidermis, localized expression of the Notch-ligand Delta in putative “stem
cells” has been proposed to induce commitment of neighboring Notch1-expressing cells to a
“transit amplifying” phenotype, a scenario reminiscent of lateral inhibition (Lowell et al.,
2000). On the other hand, expression of the Jagged 1/2 ligands and Notch 1 and 2 receptors
increases coincidentally in differentiating keratinocytes of the supra-basal layers of the
epidermis, suggesting that they are part of a positive reinforcement mechanism required for
synchronization of differentiation and epidermal border formation (Luo et al., 1997;
Rangarajan et al., 2001). In fact, an essential role of Notch1 in this process was demonstrated
by the fact that mice with a conditional keratinocyte-specific deletion of this gene show
suprabasal expression of integrins that are usually confined to the basal layer of the epidermis,
and exhibit overlapping basal and suprabasal marker expression (Rangarajan et al., 2001). A
more complex role of Notch signaling in the coordinate control of keratinocyte differentiation
along the various hair follicle lineages versus the interfollicular cell fate has been unveiled by
the concomitant deletion of the Notch1 and 2 and/or RBP-Jκ genes (Yamamoto et al., 2003;
Pan et al., 2004; Blanpain et al., 2006).
The biochemical mechanisms mediating the pro-differentiation function of Notch in
keratinocytes have been studied intensively. The cyclin/CDK inhibitor p21WAF1/Cip1 has
Dotto Page 2
Oncogene. Author manuscript; available in PMC 2009 September 21.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
emerged as an important target under positive Notch1 control in mouse keratinocytes, both in
culture and in the intact epidermis in vivo (Rangarajan et al., 2001; Nicolas et al., 2003; Lee
et al., 2007), which mediates the growth inhibitory effects of Notch1 activation (Rangarajan
et al., 2001). Increased Notch1 activity leads to increased p21 expression through two
convergent mechanisms that involve direct binding of the RBP-Jκ protein to the p21 protein
(Rangarajan et al., 2001) and RBP-Jκ-dependent activation of the calcineurin/NFAT pathway
(Mammucari et al., 2005). Importantly, in keratinocytes of hair follicles, p21 expression
appears to be under opposite Notch1 control than in the interfollicular epidermis (Lee et al.,
2007), consistent with the more complex function of this pathway in hair follicles, which can
be attributed, at least in part, to distant growth-factor mediated interactions (Lin et al., 2000).
Besides cell cycle withdrawal, two other essential aspects of keratinocyte differentiation
elicited by Notch activation are down-regulation of integrins of the basal layer and induction
of differentiation markers of the supra-basal layers (keratin 1/10, involucrin) (Rangarajan et
al., 2001; Nickoloff et al., 2002b). Down-modulation of integrins by Notch activation is not
due to a direct RBP-Jκ dependent mechanism (Rangarajan et al., 2001). As for the induction
of supra-basal differentiation markers, a recent report that they are under positive RBP-Jκ/
HES1 control (Blanpain et al., 2006) is not consistent with other publications showing an
inhibitory rather than inducing function of HES1 on these markers, both in cultured
keratinocytes and in the intact skin (Nguyen et al., 2006; Moriyama et al., 2008).
Besides intracellular regulatory mechanisms, Notch signaling is likely to impinge on
keratinocyte growth/differentiation control and skin homeostasis more indirectly, via
modulation of growth factor and cytokine production. In fact, another important consequence
of Notch activation in keratinocytes is induction of the canonical as well as non-canonical NF-
κB pathway (Nickoloff et al., 2002a; Lefort et al., 2007; Osipo et al., 2008). The role of NF-
κB dependent modulation of cytokine production by Notch signaling has not been explored in
great detail but it is an area of likely importance. Another major class of genes related to
cytokine production that are modulated by Notch in keratinocytes are genes involved in the
interferon response (Nguyen et al., 2006; Perera et al., 2006). Importantly, Notch activation
in keratinocytes causes selective suppression of some interferon responsive genes, while
inducing others, pointing to the existence of a novel mechanism for the fine tuning of these
genes, which may be of particular significance for modulation of growth-differentiation
control. In fact, several of the interferon responsive genes under Notch control in keratinocytes
(Nguyen et al., 2006), including some diffusible cytokines, have been previously implicated
in growth control, apoptosis and/or tumorigenesis (Ghosh et al., 2001; Carpten et al., 2002;
Wasylyk et al., 2002; Zhang and Pagano, 2002).
Significant differences are known to exist between growth control of cells of mouse versus
human origin (Rangarajan et al., 2004). These extend to keratinocytes and their different
response to Notch activation (Nguyen et al., 2006). Notch1 activation triggers direct cell cycle
withdrawal of mouse primary keratinocytes (Rangarajan et al., 2001); in keratinocytes of
human origin it has less immediate effects, causing these cells to replicate for a limited number
of times with a subsequent loss of clonogenic potential (Lowell et al., 2000; Nguyen et al.,
2006; Lefort et al., 2007). At the transcriptional level, only a restricted subset of genes is
similarly controlled by Notch1 activation in the two types of cells (Nguyen et al., 2006). Among
the commonly regulated genes is p63 (Nguyen et al., 2006), a p53 family member with a
selective essential function in keratinocyte cell fate determination and/or stem cell maintenance
(Mills et al., 1999; Yang et al., 1999). Besides its role in skin development, p63 is likely to
play a significant function after birth, preventing differentiation (King et al., 2003; Koster and
Roop, 2004) and premature senescence (Keyes et al., 2005). Importantly, elevated expression
of this gene has also been associated with a variety of epithelial tumors, including squamous
cell carcinomas (Parsa et al., 1999; Pellegrini et al., 2001; Westfall and Pietenpol, 2004), in
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which Notch1 expression and activity are downmodulated (Lefort et al., 2007), suggesting that
the two are linked. In fact, in keratinocytes of both murine and human origin, there is a
reciprocal negative feedback loop between Notch and p63. On one hand, p63 expression is
suppressed by Notch activation through a novel mechanism involving the selective modulation
of interferon responsive genes mentioned above (Nguyen et al., 2006). On the other hand,
persistently elevated p63 expression counteracts the growth inhibitory effects of Notch
activation, while synergizing with other aspects of Notch function involved in the early stages
of differentiation (Nguyen et al., 2006; Truong et al., 2006; Okuyama et al., 2007).
Besides p63, Smad proteins have also been shown to functionally and biochemically interact
with activated Notch1 (Blokzijl et al., 2003; Itoh et al., 2004; Zavadil et al., 2004). This can
be relevant for the tumor suppressing function discussed below, as recent results point to the
synergism of Notch and TGF-β signaling in keratinocyte growth inhibition, with
p21WAF1/Cip1 as an important downstream target (Niimi et al., 2007).
Tumor suppressor function of Notch in mouse keratinocyte tumor
development
Mouse skin is a classical experimental system for epithelial tumor development, where the
notion of multistep chemical carcinogenesis has been originally defined (Yuspa, 1991). Notch
signaling plays an important tumor suppressing function in this context. In fact, keratinocyte-
specific deletion of the Notch1 gene results in a substantially increased susceptibility to
chemical or ras-induced skin carcinogenesis (Nicolas et al., 2003), with similar effects being
observed after deletion of the Delta like 1 (Estrach et al., 2008) or γ-secretase (Xia et al.,
2001; Li et al., 2007) genes, or expression of a dominant negative peptide suppressing Notch/
CSL dependent transcription (Proweller et al., 2006) (MAM51, as also discussed further
below).
Importantly, loss of the Notch1 gene mirrors the effects of loss of p21WAF1/Cip1 on both
keratinocyte stem cell populations (Topley et al., 1999) as well as ras- (Missero et al., 1996)
and chemically induced skin carcinogenesis (Philipp et al., 1999; Topley et al., 1999; Weinberg
et al., 1999). The common biological function of Notch1 and p21 as negative regulators of
keratinocyte self renewal and tumorigenesis can be explained, at least in part, by suppression
of Wnt signaling (Nicolas et al., 2003; Devgan et al., 2005). Activation of the Wnt/β-catenin
pathway has been associated with keratinocyte stem cell populations (Zhu and Watt, 1999) and
keratinocyte-derived tumors (Gat et al., 1998), while, conversely, β-catenin gene deletion
results in decreased skin cancer stem cell populations (Malanchi et al., 2008). Genetic analysis
in developmental model systems has pointed to a complex cross-talk between the Notch and
Wnt signaling pathways, which can occur at multiple levels (Couso and Martinez Arias,
1994; Axelrod et al., 1996; Galceran et al., 2004; Hofmann et al., 2004). In mouse keratinocytes
and skin, Notch was found to negatively regulate Wnt signaling through a novel mechanism
involving down-modulation of Wnt ligand gene expression, specifically and Wnt4. Importantly,
p21 is a key mediator of the negative regulation of Wnt4 expression, binding to the promoter
region of this gene and functioning downstream of Notch, at the transcription-chromatin level
and separately from effects on the cell cycle (Devgan et al., 2005).
Besides p21WAF1/Cip1 and Wnts, Notch signaling has been shown to affect other molecules
and pathways with a key regulatory function in keratinocyte tumor development. Unlike p21
−/− mice, mice with the Notch1 deletion develop also spontaneous skin tumors in various parts
of the body, with histological features similar to those of basal cell carcinomas (BCCs) (Nicolas
et al., 2003). Consistent with this phenotype, Notch1 deficiency is associated with increased
and sustained expression of Gli2, a downstream target of the sonic hedgehog (SHH) signaling
pathway that has been causally linked to BCC tumor formation (Nicolas et al., 2003). Another
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distinguishing characteristic of mice with a keratinocyte-specific deletion of the Notch1 gene
is the development of extensive hyperplasia and keratinization of the corneal epithelium that
results in opaque plaque formation and blindness (Nicolas et al., 2003). The underlying
mechanism has been linked to defective vitamin A metabolism (Vauclair et al., 2007), whose
role in keratinocyte tumor formation has been previously intensely investigated (Altucci and
Gronemeyer, 2001).
Role of Notch1 in human keratinocyte tumor suppression
The genetic studies discussed above demonstrate that Notch signaling, and more specifically
Notch1, acts as a tumor suppressor in mouse skin. A key question is whether this tumor
suppressing function is a peculiarity of the mouse skin system or applies also to the human
situation. This is an important issue, given the tumor promoting function commonly attributed
to Notch signaling and its clinical implications (Miele et al., 2006). Even for human
keratinocytes, as discussed in an accompanying review (Krishna), it was originally proposed
that Notch1 activation cooperates with HPV-induced cervical carcinogenesis, through a
mechanism involving an increase in cell survival (Rangarajan et al., 2001; Nair et al., 2003).
This is consistent with the original finding (Zagouras et al., 1995), confirmed by later reports
((Ramdass et al., 2007) and refs. therein), that Notch1 receptor expression is elevated in cervical
carcinomas. However, in light of the normal pro-differentiation function of Notch activation
in normal keratinocytes (Lowell et al., 2000; Rangarajan et al., 2001; Nickoloff et al., 2002a;
Nguyen et al., 2006; Lefort et al., 2007), elevated expression of the Notch1 receptor in cervical
carcinomas could also be interpreted as a marker of differentiation, expressed in the more
differentiated parts of these tumors. Consistent with this interpretation is the heterogeneous
pattern of Notch1 expression, decreased rather than increased in the less differentiated areas
of aggressive cervical cancer (Talora et al., 2002), and the fact that HPV-positive cervical
carcinoma cell lines express significantly lower levels of the Notch1 protein than corresponding
normal primary keratinocytes (Talora et al., 2002; Yugawa et al., 2007). Such down-
modulation of Notch1 expression and activity may be required for tumor development, as
expression of activated Notch1 in cervical cancer cells results in drastic growth suppression
(Talora et al., 2002; Wang et al., 2007; Yao et al., 2007). This is not due to a-specific toxic
effects, but can be explained by suppression of HPV oncoprotein expression, through inhibition
of endogeous AP-1 activity (Talora et al., 2002), and/or additional more indirect mechanisms
(Talora et al., 2005; Yao et al., 2007).
As in cervical carcinoma cells, the proliferative potential of primary human keratinocytes is
suppressed by increased Notch activity (Lowell et al., 2000; Nguyen et al., 2006; Lefort et
al., 2007). To assess whether suppression of endogenous Notch signaling has converse tumor-
promoting effects, two complementary approaches were undertaken. Expression of a 51 amino
acid peptide corresponding to the N-terminus of the Mastermind-like 1 protein (MAM51)
provides an effective way to suppress Notch/CBF-1-dependent transcription (Weng et al.,
2003). This method was previously used to suppress Notch signaling and inhibit tumorigenic
behavior of T cell lymphomas as well as melanomas (Weng et al., 2003; Maillard et al.,
2004; Balint et al., 2005). In sharp contrast, this same approach increased dramatically the
susceptibility of primary human keratinocytes to transformation by a ras oncogene, with
formation of tumors closely resembling clinically aggressive SCCs (Lefort et al., 2007). As a
second approach, ras-expressing human keratinocytes were tested by skin-reconstitution
assays onto mice, under conditions that result, under normal conditions, in well stratified
epidermis (Dotto et al., 1989). Under control conditions, the ras expressing keratinocytes
produced a hyperplastic epithelium with only limited sites of invasion. By contrast, treatment
with a γ-secretase inhibitor, to suppress endogenous Notch activation, resulted in aggressive
tumor formation (Lefort et al., 2007).
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Previous studies have reported oncogenic conversion of primary human keratinocytes by
concomitant expression of oncogenic ras and suppression of NF-κB, through a mechanism
that promotes growth through TNF/JNK activity (Dajee et al., 2003; Zhang et al., 2004). Since
Notch activation leads to induction of NF-κB (Nickoloff et al., 2002a; Nguyen et al., 2006;
Shin et al., 2006), an attractive possibility was that the tumor suppressing function of Notch
in keratinocytes is mediated by NF-κB. However, while suppressing “canonical” CBF-1
dependent transcription, expression of the MAM51 peptide did not affect NF-κB activity and
had no direct growth promoting effects on the total keratinocyte cell population (Lefort et
al., 2007).
As pointed out in a recent review (Merlo et al., 2006), increased growth potential and/or
“immortalization” are not necessary characteristics of the majority of cells in primary tumors.
What may be more relevant instead are “cancer stem cell populations”, representing a minor,
possibly slow cycling fraction of cells that give rise to all other heterogeneous tumor cell
populations (Merlo et al., 2006). Consistent with this possibility, Notch suppression causes the
expansion, over time, of a minor subpopulation of keratinocytes with high self-renewing
potential (Lefort et al., 2007). In this context, the negative cross-talk between Notch1 and p63
discussed above can play an important role (Nguyen et al., 2006). However, p63 expression is
down-regulated by Notch activation through a CBF-1 and Hes-independent mechanism not
affected by MAM51 expression (Nguyen et al., 2006; Lefort et al., 2007).
Like p63, small GTPases of the Rho, Rac and CD42 families have been recently implicated in
keratinocyte cell fate determination and/or stem cell potential (Xu et al., 2003; Benitah et al.,
2005; Dotto and Cotsarelis, 2005; Wu et al., 2006), and increased Rho signaling has been
connected with tumor progression (Sahai and Marshall, 2002). Importantly, no genetic
mutations have been uncovered which are responsible for activation of this pathway in tumors.
Searching for “canonical” CBF-1 dependent mechanisms involved in keratinocyte tumor
suppression, the ROCK1/2 and MRCKα kinases, two key effectors of Rho GTPases over-
expressed in tumors, were found to be under negative Notch/HES control (Lefort et al.,
2007). Importantly, the combined knockdown of these kinases could counteract the effects of
Notch suppression in keratinocytes both in vitro and in vivo, pointing to an inverse relationship
between Notch and Rho signaling in control of stem cell potential and tumorigenesis (Lefort
et al., 2007).
Notch 1 is a tumor suppressor gene under direct p53 control
Tumor suppressor genes are classically defined as genes whose mutation or loss are required
for tumor development (Hahn and Weinberg, 2002). However, the importance of epigenetic
mechanisms for down-modulation of negative growth regulatory genes and tumorigenesis is
increasingly recognized (Gius et al., 2004). Consistent with the tumor suppressing function of
Notch signaling in keratinocytes, Notch activity is significantly reduced in the two major types
of non-melanoma skin cancer, squamous cell carcinomas (SCCs) and basal cell carcinomas
(BCCs) (Thelu et al., 2002; Lefort et al., 2007). Expression of the Notch1 gene itself is down-
regulated, at the transcriptional level, with less pronounced effects for Notch2.
Surprisingly little is known of transcriptional control mechanisms of Notch receptor genes,
although this can be an important mode of regulation of Notch activity. A recent global survey
of the human genome pointed to the Notch1 promoter as a possible p53 binding target (Wei
et al., 2006). Given the high frequency of p53 mutations in skin SCCs (http://p53.free.fr), an
attractive possibility was that down-modulation of Notch1 expression occurring in these tumors
is due, at least in part, to compromised p53 function. In fact, in primary human keratinocytes,
endogenous p53 binds to the Notch1 promoter and p53 knock-down in these cells results in
down-modulation of Notch1 expression (Lefort et al., 2007; Mandinova et al., 2008).
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Conversely, increased p53 levels, by either exogenous expression or stabilization of the
endogenous protein (via MDM2 inhibition), leads to Notch1 up-regulation in normal
keratinocytes and, to a substantial greater extent, in SCC cells (Lefort et al., 2007).
In cervical carcinogenesis, the HPV E6/E7 oncogenes are expressed at low levels in low-grade
intraepithelial neoplasias, while they are abundantly expressed in high-grade malignant lesions,
with deregulated expression of these viral oncogenes being a key element for neoplastic
progression (zur Hausen, 2000). The major target of the viral E6 protein is p53, which is
targeted by E6 for degradation. Elegant genetic and biochemical studies showed that E6-
dependent degradation of p53 is responsible for the strongly reduced levels of Notch1
expression in HPV-positive cervical carcinoma cells (Yugawa et al., 2007). Even in this case
p53 was found to regulate specifically Notch1 expression, with little or no effect on Notch2
(Yugawa et al., 2007).
As p53 and p63 share a common DNA recognition sequence (Yang et al., 1998), an attractive
possibility is that p63 can also participate in control of Notch1 gene transcription. Consistent
with this possibility is the lack of Notch1 expression in the epidermis of mice with p63 deletion
during development (Laurikkala et al., 2006). However, in mature keratinocytes, p63
counteracts downstream Notch signaling (Nguyen et al., 2006) with little or no effect on Notch1
gene expression ((Yugawa et al., 2007); Kolev et al., submitted).
Besides keratinocytes, similar regulation of Notch1 expression by p53 occurs in lung and
prostate cancer cells, other cell types in which increased Notch signaling causes growth
inhibition with possible tumor suppressing effects ((Alimirah et al., 2007; Yugawa et al.,
2007); Lefort et al, submitted). In contrast, no such regulation was observed in colon carcinoma
cells or fibroblast-derived cell lines, pointing to a likely interplay between p53 and other cell
type-specific regulators in control of Notch1 gene transcription (Lefort et al., 2007; Yugawa
et al., 2007).
Notch activity can also be controlled by p53 at the post-transcriptional level, as suggested by
the finding that in T cells p53 can down-modulate Notch signaling through negative regulation
of presenilin expression (Laws and Osborne, 2004). Conversely, Notch activity can mediate
and/or modulate p53 function. In human cell types where it promotes tumor formation, Notch
signaling was reported to act upstream of p53, suppressing its function (Beverly et al., 2005;
Mungamuri et al., 2006). In keratinocytes, the finding that p53 is an upstream positive regulator
of Notch1 raises the interesting possibility that p53 and Notch1 share common transcriptional
targets, and the transcriptional response of one may depend, in part, on the other. This was
shown to be indeed the case for at least one significant class of genes under Notch1 control,
the ROCK1/2 and MRCKα kinases which are similarly regulated by increased p53 activity, in
a manner which is, in the case of MRCKα, partially dependent on the Notch pathway (Lefort
et al., 2007).
Protective anti-apoptotic function of Notch signaling: at the cross-road
between tumor promotion and suppression
UV light is a major etiological agent of skin aging and cancer (de Gruijl, 1999; Armstrong and
Kricker, 2001). p53 plays a key role in the UV/DNA damage response of cells, controlling the
decision between growth arrest and apoptosis (Latonen and Laiho, 2005; D’Errico et al.,
2007). The recent finding that Notch1 is a p53 target gene in keratinocytes pointed to the
possibility that this gene is also implicated in the UVB/DNA damage response of these cells.
In fact, UVB exposures of keratinocytes, in culture as well as in the skin, induces Notch1 gene
expression in a p53-dependent manner, with similar induction being caused by genotoxic
DNA-damaging agents (Yugawa et al., 2007; Mandinova et al., 2008). Such regulation is
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physiologically relevant, as analysis of mice with a keratinocyte-specific deletion of the Notch1
gene as well as keratinocytes with Notch suppression showed that this gene plays a significant
protective function against UVB-induced apoptosis (Mandinova et al., 2008).
As for its role in growth/differentiation control, Notch signaling can exert either a pro- or anti-
apoptotic function through multiple mechanisms that are highly cell- and context-dependent
(Oswald et al., 1998; Jehn et al., 1999; Nair et al., 2003; MacKenzie et al., 2004; Oishi et
al., 2004; Sade et al., 2004; Yang et al., 2004; Kim et al., 2005; Zweidler-McKay et al.,
2005). In the keratinocyte UVB response, the pro-survival function of Notch is linked to
transcriptional down-modulation of FoxO3a, a key pro-apoptotic gene (Mandinova et al.,
2008). This occurs without detectable changes in PI3K/Akt-dependent phosphorylation that is
a major form of FoxO3a regulation (Brunet et al., 1999). Rather, the “canonical” Notch/HERP
pathway is an important negative regulator of FoxO3a expression, through a mechanism
involving binding of the HES/HERP/Tle transcription repressor complex to the FoxO3a
promoter (Mandinova et al., 2008).
FoxO3a is a transcription factor with multiple cellular functions, ranging, like Notch, from cell
cycle control and differentiation to apoptosis (Burgering and Kops, 2002). In human
keratinocytes, FoxO3a was recently found to control a subset of genes with cell cycle regulatory
function (p21WAF1/Cip1 and p15INK4b), mediators of stress responses (like Gadd45α and β) and
adaptive cell signaling (like Jagged1, CDC42EP3, OVOL1) (Gomis et al., 2006), some of
which are also under Notch control in these cells ((Nguyen et al., 2006); our unpublished
observations). Thus, an intriguing possibility is that FoxO3a participates in the already
established cross-talk between Notch and other signaling pathways discussed in this review.
Irrespective of the detailed mechanism, the dual role of Notch in promoting commitment of
keratinocytes to differentiation and, concomitantly, increasing their cell survival has important
implications for possible therapeutic approaches based on targeting of this pathway. Based on
our experimental evidence, we suggest that treatment with single general inhibitors of Notch
activity (like γ-secretase inhibitors) can have detrimental tumor-promoting effects in the skin
and possibly other organs where this pathway exerts a similar function. More promising
approaches may be provided instead by selective inhibitors that can suppress the Notch pro-
survival function while leaving intact or enhancing its ability to induce differentiation, or by
a combination therapy based on Notch inhibitors in conjunction with other compounds with
growth inhibitory and/or pro-differentiation activity.
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Figure 1. Cross-regulation of Notch with other key signaling pathways in keratinocyte stem self
renewal, differentiation and/or tumorigenesis
A dynamic equilibrium exists in the skin among keratinocyte stem cells, transit amplifying
populations, and cells that have exited the cell cycle and are committed reversibly versus
irreversibly to differentiation. As discussed in the text, such equilibrium is controlled by an
inverse gradient and reciprocal negative regulation of p63 expression and Notch activity in the
lower versus upper epidermal layers. p63 suppresses Notch signaling in epidermal cells with
high self-renewal potential, while synergizing with other aspects of Notch function in early
stages of differentiation. Notch1 and p21WAF1/Cip1, a “canonical” Notch target in
keratinocytes, suppress Wnt ligand expression and signaling, and function as negative regulator
of stem cell potential and tumorigenesis. In fact, UV light exposure is a major etiological agent
of human skin cancer, and the Notch1 gene is a p53 target with a key role in human keratinocyte
tumor suppression.
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Figure 2. Duality of Notch functions in keratinocyte commitment to differentiation and cell survival
Notch signaling impacts on, and is regulated by a complex signaling network with an important
role in skin homeostasis and tumor development. Like Notch, many other components of this
network exert a duality of functions, impinging on keratinocyte growth/differentiation control
as well as cell survival. This has potentially important implications for cancer therapy. An
attractive approach could be the use of selective inhibitors, which can suppress the Notch pro-
survival function while leaving intact or enhancing its ability to induce differentiation.
Alternatively, Notch inhibitors, or inducers, could be used as part of a combination therapy
based on in conjunction with other compounds with growth inhibitory and/or pro-apoptotic
functions.
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